Scarring alopecia: protecting the hair you still have

Hair loss with scalp symptoms deserves assessment

Arrange a GP appointment if hair loss is accompanied by persistent itching, burning or scalp pain; your GP can refer you to a dermatologist. Redness around individual hairs, adherent scale, crusts or spots containing pus can also guide investigations. These signs are not specific to scarring alopecia: they indicate a need for assessment rather than a way to identify the condition at home.

A lack of pain does not rule out an inflammatory disorder. Some forms progress quietly, with thinning that becomes noticeable over several months or a change in the hairline. Waiting for severe irritation before seeking help may therefore delay diagnosis, particularly when the earliest changes are subtle.

The clinician also examines the skin between the hairs. A reduction in visible follicular openings may suggest scarring, but this needs suitable equipment and interpretation in context. A smooth patch, an enlarged photograph or comparison with an online image cannot establish that distinction on its own.

Before your appointment, try to recall when the changes began and which areas were affected first. Mention symptoms, treatments you have tried, any previous scalp injury and your usual styling practices. Older photographs may help explain the course of the problem, although they cannot replace an examination of the scalp and hair.

What scarring means for hair regrowth

The visible hair is produced by a follicle within the skin. When the structures that support the follicle’s renewal are destroyed, fibrous scar tissue can take their place. A follicle lost in this way cannot start producing hair again in response to a shampoo, oil or dietary supplement.

That irreversible loss concerns destroyed follicles, which are not necessarily all the follicles within an area that looks thin. The same patch may contain functioning follicles, others affected by disease and established scars. Treating active disease can therefore remain worthwhile even after some permanent loss has occurred, because the aim is to preserve what can still be protected.

The general term alopecia also covers conditions that do not usually involve this type of scarring destruction. Alopecia areata, for example, has a different mechanism, while pattern hair loss mainly involves progressive follicular miniaturisation. A prolonged absence of visible regrowth does not, by itself, prove that the follicles have disappeared.

Alopecia areata can also produce bald patches with apparently smooth skin. Its course and treatment cannot simply be applied to scarring conditions. Equally, an isolated bald patch does not automatically mean permanent destruction is occurring: an assessment is needed to establish the nature of the loss.

Several conditions can lead to scarring

Clinicians distinguish primary forms, in which inflammation targets the follicle, from secondary forms, where follicles are damaged during a wider injury to the skin. This explains why two people with a hairless area may need different care. The distinction is not a severity scale and does not, on its own, predict the future course of the condition.

Primary forms include lichen planopilaris, some manifestations of cutaneous lupus and folliculitis decalvans. Lichen planopilaris may cause scaling around individual hairs and varying degrees of discomfort. Folliculitis decalvans often involves pustules and crusting, but diagnosis depends on the overall findings and sometimes additional samples.

Frontal fibrosing alopecia also belongs to this group and needs its own assessment. It can alter the frontal hairline and involve eyebrow loss. Including it among scarring alopecias does not mean every condition in the group has the same distribution, associated factors or response to treatment.

Central centrifugal cicatricial alopecia often begins at the crown and extends outwards. It particularly affects women of African descent, but should not be reduced to a consequence of their hairstyles. Evidence points to several contributing factors, including genetic susceptibility; it is distinct from traction alopecia, although both conditions can occur together.

Secondary scarring may follow a deep burn, trauma or certain injuries associated with radiotherapy. Repeated traction can also become scarring when lasting damage develops. The history helps establish how a scar arose, but an old injury and a primary inflammatory disease require different assessments before reconstruction is considered.

Why assessment involves more than a blood test

The dermatologist considers the distribution of hair loss, signs of inflammation and the hairs that remain. Trichoscopy uses a magnifying instrument to examine details of the scalp that are difficult to see with the naked eye. It can also help identify the most informative site if a sample is needed.

A scalp biopsy is often needed to identify the inflammatory disease responsible for suspected scarring alopecia. It is not routinely required for a scar already known to result from an injury. Under local anaesthetic, a small skin sample is taken for laboratory examination to identify follicular damage and the pattern of inflammation, then interpret those findings alongside the clinical examination.

The sampling site matters: an area with remaining hairs and signs of inflammatory activity may reveal more than a completely scarred centre. In advanced disease, different conditions can leave similar appearances and become difficult to distinguish. A biopsy therefore does not provide an automatic, infallible answer; its interpretation also depends on sample quality and the information supplied to the pathologist.

Additional investigations are chosen according to the findings. Microbiological samples may be useful when pustules are present, while blood tests address particular questions raised by the history or examination. Normal blood results cannot exclude a follicular disorder, and no single blood test describes the whole group of scarring alopecias.

More than one cause may need to be considered in the same person. Androgenetic alopecia can coexist with inflammatory disease and contribute to the overall reduction in hair volume. Separating those components helps avoid expecting one treatment to address several different mechanisms.

Treatment starts with preserving follicles

When an inflammatory disease is active, treatment aims to reduce that activity, relieve symptoms and limit further loss. The choice depends on the diagnosis, extent of involvement, changes over time and your general health. A prescription used by someone else, or for another type of alopecia, is not a suitable template for your own care.

Depending on the condition, a dermatologist may use corticosteroids applied to the skin or injected into selected areas, alongside medicines that affect inflammation or immune activity. Antibiotics have a role in some forms, particularly when a bacterial contribution needs to be addressed. A doctor determines their indication, duration and monitoring because these approaches are neither interchangeable nor suitable for everyone.

Minoxidil may sometimes be considered as an additional treatment for remaining follicles or another coexisting cause of thinning. It does not recreate a follicle replaced by scar tissue and cannot substitute for controlling inflammation that is destroying follicles. Similarly, a cosmetic product may improve comfort or the appearance of existing hair without treating the underlying disease.

Visible regrowth is not the only measure of progress. Reduced symptoms and no newly affected areas may represent meaningful improvement even when the scar remains visible. Responses vary, and follow-up allows the plan to be adjusted when control is inadequate or treatment is poorly tolerated.

Monitoring change without constant comparison

Monitoring combines your experience with the clinician’s observations. Photographs taken under comparable conditions can document the size of an affected area, while examination looks for more subtle signs. A reassuring photograph or a few weeks without itching cannot, on their own, establish that the disease is inactive.

Appointment frequency depends on the diagnosis and the treatment being used. Report new pain, pustules or visible spread instead of always waiting for a scheduled review. Do not change a prescription solely because hair has not regrown: its purpose may be to protect the follicles you still have.

The effect on confidence also deserves attention within your care. A wig or hairpiece, a different hairstyle or other camouflage options can be discussed according to the condition of your scalp. If hair loss is affecting your relationships, sleep or daily life, speaking to a healthcare professional can help you find appropriate support.

Transplantation follows assessment of the disease

A transplant moves follicles from a donor region into an area with hair loss; it does not remove the cause of scarring alopecia. With active inflammation, treating the condition and assessing its course remain the priorities. The general steps in our hair transplant guide therefore need to be considered within this particular medical context.

Reconstruction may be discussed in selected cases when specialists consider the disease sufficiently controlled. They assess donor hair quality, the recipient scar, its blood supply and the history of inflammatory flares. A symptom-free interval or a predetermined waiting period is not enough to make surgery appropriate for everyone.

The review published by Queen and Avram in 2025 highlights differences between conditions and the shortage of robust long-term evidence. Transplanted follicles may grow poorly or later be affected if inflammation returns. Figures from small series of carefully selected patients cannot calculate your personal chance of a lasting outcome.

A limited test transplant may sometimes be proposed to observe how the skin responds before considering a larger procedure. Even a favourable test cannot predict with certainty how grafts will fare over the years. The discussion also needs to cover alternatives, subsequent dermatological follow-up and the possibility of avoiding surgery when conditions remain unsuitable.

Preparing a realistic plan with Body Expert

At Body Expert, we encourage you to gather any existing dermatological diagnosis, biopsy report and treatment history. These provide useful context when considering a project, without replacing the medical examination required. An enquiry should not delay a consultation when hair loss is accompanied by inflammatory symptoms.

If reconstruction is medically appropriate, our team can explain the pathway for a hair transplant in Istanbul. Planning needs to account for the limitations of your scalp and the follow-up required for the original condition. The aim is an informed decision, including when continuing medical care or choosing camouflage is the most appropriate option.

Sources

Cummins, D. M., Chaudhry, I. H., & Harries, M. (2021). Scarring alopecias: Pathology and an update on digital developments. Biomedicines, 9(12), 1755. https://doi.org/10.3390/biomedicines9121755

Herskovitz, I., & Miteva, M. (2016). Central centrifugal cicatricial alopecia: Challenges and solutions. Clinical, Cosmetic and Investigational Dermatology, 9, 175–181. https://doi.org/10.2147/CCID.S100816

Queen, D., & Avram, M. R. (2025). Hair transplantation in primary cicatricial alopecias: A review and update. Surgeries, 6(4), 80. https://doi.org/10.3390/surgeries6040080

NHS. (2024, January 24). Hair loss. https://www.nhs.uk/symptoms/hair-loss/